Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma
伊沙妥昔单抗单药治疗中国复发/难治性多发性骨髓瘤患者的I期研究
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-59186-1
Sun, Mingyuan; Jing, Hongmei; Qu, Xiaoyan; Dong, Fei; Li, Yi; Feng, Zhaoyi; Ziti-Ljajic, Samira; Semiond, Dorothee; Li, Lingyu; Qi, Junyuan; Qiu, Lugui